Skip to main content
CODX
NASDAQ Life Sciences

Co-Diagnostics Advances Ebola Assay Development with CoSara Amid Global Health Emergency

Tom Rudovsky · Reported by PR Newswire
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$6.97
Mkt Cap
$18.264M
52W Low
$1.26
52W High
$46.5
52W Position info
453% above low
Off High info
85% below high
Rel. Volume info
1.9× avg
Market data snapshot near publication time

CODX has more than doubled off its 52-week low of $1.26 on elevated volume (1.9× avg).

Summary

Co-Diagnostics is advancing its PCR assay development strategy for the Bundibugyo virus (Ebola) with its Indian joint venture, CoSara Diagnostics. This development comes as the World Health Organization recently declared the Ebola outbreak a public health emergency. The company faces significant financial challenges, including a 'going concern' warning, substantial losses, and recent dilutive financing through an S-3 shelf registration for $150 million and a $3 million private placement. While this product development could provide a future revenue stream and address a critical global need, the product is still in development and not yet available for sale, limiting immediate financial impact.

At the time of this announcement, CODX was trading at $6.97 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $18.3M. The 52-week trading range was $1.26 to $46.50. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

CODX - Latest Insights

CODX
Nov 04, 2026, 4:45 PM EST
Filing Type: S-3
Importance Score:
8
Price at Filing: $0.3615
Real-time Price: $0.3569 info
Change: -$0.0046 (-1%) info
Market Cap: $3.189M info
CODX
Oct 26, 2026, 4:00 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $0.5459
Real-time Price: $0.3569 info
Change: -$0.189 (-35%) info
Market Cap: $3.189M info
CODX
Oct 19, 2026, 12:28 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.6726
Real-time Price: $0.3569 info
Change: -$0.3157 (-47%) info
Market Cap: $3.189M info
CODX
Oct 15, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.7201
Real-time Price: $0.3569 info
Change: -$0.3632 (-50%) info
Market Cap: $3.189M info
CODX
Oct 13, 2026, 6:10 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.23
Real-time Price: $0.3569 info
Change: -$0.8731 (-71%) info
Market Cap: $3.189M info